PMF Interviews Dr. Bettina Lundgren, CEO and Managing Director, Danish National Genome Centre
CEO and Managing Director, of the Danish National Genome Centre, insights into the Danish Government’s Healthcare system.
CEO and Managing Director, of the Danish National Genome Centre, insights into the Danish Government’s Healthcare system.
The next interview in our Nordic Precision Medicine Forum 2020/21 series is one we conducted with Dr. Toni Andreu, Scientific Director, EATRIS.
PMF Interviews Dr. Toni Andreu, Scientific Director, EATRIS Read More »
PMF Interviews Dr Valtteri Wirta, Speaker at the Virtual Nordic Precision Medicine Forum 2020/2021
PMF Interviews Dr Valtteri Wirta, Speaker at Nordic Precision Medicine Forum 2020/2021 Read More »
Perelman School of Medicine at the University of Pennsylvania will use artificial intelligence to find patterns in genetic, imaging, and clinical data from over 60,000 Alzheimer’s patients.
Artificial Intelligence to be used in a study for Alzheimer’s Drug Development Read More »
In the state’s budget released this week, the Norwegian Government raised the funding for personalised medicine by NOK 30 million to a total of NOK 61,3 million.
Norwegian Government increases Precision Medicine state funding to NOK 61,3 Million Read More »
Researchers at UC San Diego Health claimed that while next-generation sequencing can help identify novel cancer targets.
Outcomes for Cancer Patients improve due to Precision Medicine Treatments Read More »
The study being funded by NIH, in the US, will involve 20 research centres to better understand unusual types of diabetes.
National Institutes of Health funds study to progress Precision Medicine for Diabetes Read More »
The National institute for Health and Care Excellence (NICE) has approved the drug osimertinib (Tagrisso) that can be used to treat some adults with advanced lung cancer.
Targeted Drug to treat Lung Cancer approved for NHS use in England Read More »
The European Society for Medical Oncology (ESMO) Resilience Task Force suggests cancer professionals are suffering from higher levels of burnout due to Covid-19.
Cancer Professionals suffering higher levels of Burnout due to Covid-19 Read More »
The new international collaboration will connect experts in medicine, drug discovery, and artificial intelligence with the aim of finding new treatments for common and rare diseases.